Dyne Therapeutics (DYN) PT Raised to $35 at RBC Capital
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $25.10 -1.3%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 19
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 19
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Evonik Industries AG (EVK:GR) (EVKIF) PT Raised to EUR22 at Citi
- SThree Plc. (STEM:LN) (STREF) PT Raised to GBP3.30 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
